Clinical Trial Update: Evaluating Novel Therapies in ctDNA Positive GI Cancers [Phase 3]

View source ↗

Summary

Georgetown University is conducting a Phase 3 trial evaluating novel therapies for ctDNA-positive gastrointestinal cancers, currently recruiting across several …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of Biliary Tract
• Colon Adenocarcinoma
• Gallbladder Adenocarcinoma
• Gastric Adenocarcinoma
• Hepatocellular Carcinoma
• Pancreatic Adenocarcinoma
• Rectal Adenocarcinoma

Snippet

Sponsor: Georgetown University | Conditions: Colon Adenocarcinoma, Rectal Adenocarcinoma | Phase 3 | Status: RECRUITING